Valuation Astal Laboratories Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 13:00:58 17/06/2026 +03			5-day change	1st Jan Change
81.38 ^INR	-1.70%		+13.82%	-6.30%

05-30	Astal Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
02-14	Astal Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	36.52	34.77	64.34	118.1	401.9	747.2
Change	-	-4.79%	85.03%	83.54%	240.29%	85.93%
Enterprise Value (EV) ¹	36.38	34.46	64.16	117.2	344.2	862.6
Change	-	-5.27%	86.18%	82.75%	193.57%	150.59%
P/E	-130x	577x	-376x	722x	26.3x	9.45x
PBR	0.71x	0.67x	1.25x	2.27x	1.72x	2.08x
PEG	-	-5x	1x	-4x	0x	0x
Capitalization / Revenue	18.1x	17.2x	30.5x	3.27x	1.7x	1.17x
EV / Revenue	18x	17.1x	30.4x	3.25x	1.45x	1.36x
EV / EBITDA	-	-	-	-	-	-
EV / EBIT	-	-	-	-	-	-
EV / FCF	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.0708	0.0152	-0.0431	0.041	1.554	8.043
Distribution rate	-	-	-	-	-	-
Net sales ¹	2.019	2.019	2.108	36.07	236.6	636.6
EBITDA	-	-	-	-	-	-
EBIT	-	-	-	-	-	-
Net income ¹	-0.2815	0.0602	-0.1711	0.164	7.847	89.25
Net Debt ¹	-0.1448	-0.3129	-0.1828	-0.844	-57.64	115.4
Reference price ²	9.19	8.75	16.19	29.60	40.88	76.01
Nbr of stocks (in thousands)	3,974	3,974	3,974	3,990	9,830	9,830
Announcement Date	9/10/20 A	9/1/21 A	9/8/22 A	8/25/23 A	7/12/24 A	8/18/25 A

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ASTAL LABORATORIES LIMITED	-	-	-	-	38.25M
ELI LILLY AND COMPANY	32.85x	11.94x	24.59x	0.61%	1,001B
JOHNSON & JOHNSON	25.13x	5.79x	15.76x	2.27%	566B
ABBVIE INC.	27.6x	6.65x	13.6x	3.09%	393B
ROCHE HOLDING AG	17.38x	4.29x	10.55x	3.09%	326B
NOVARTIS AG	20.88x	5.41x	13.12x	2.97%	276B
ASTRAZENECA PLC	22.34x	4.67x	13.24x	1.87%	277B
NOVO NORDISK A/S	12.39x	4.65x	9.51x	4.05%	193B
AMGEN INC.	22.62x	6.06x	10.58x	2.9%	188B
GILEAD SCIENCES, INC.	-45.59x	5.5x	30.32x	2.55%	158B
Average	15.07x	6.11x	15.70x	2.6%	337.68B
Weighted average by Cap.	22.21x	7.38x	17.24x	2.13%